Teplizumab: type 1 diabetes mellitus preventable?
Crossref DOI link: https://doi.org/10.1007/s00228-023-03474-8
Published Online: 2023-04-01
Published Print: 2023-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Misra, Saurav
Shukla, Ajay Kumar
Text and Data Mining valid from 2023-04-01
Version of Record valid from 2023-04-01
Article History
Received: 14 February 2023
Accepted: 8 March 2023
First Online: 1 April 2023
Declarations
:
: Not applicable.
: The authors declare no competing interests.